Namandje N. Bumpus's most recent trade in Recursion Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 22,016 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals ... | Namandje N. Bumpus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 22,016 | 22,016 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Namandje N. Bumpus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 11,008 | 47,557 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Namandje N. Bumpus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 73,099 | 73,099 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Namandje N. Bumpus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 36,549 | 36,549 | - | 0 | Class A Common Stock |